Blog
RSS FeedPosted by Michael Wonder on 23 Apr 2020
COVID-19: Critical Care Advisory Group
23 April 2020 - In April 2020, PHARMAC convened a group of clinical experts from across New Zealand for an ...
Posted by Michael Wonder on 23 Apr 2020
Recent PHARMAC funding decisions
22 April 2020 - You may have read about PHARMAC’S decision this week to scrap a lung cancer drug funding ...
Posted by Michael Wonder on 17 Apr 2020
COVID-19: Government funds $276m for PPE, PHARMAC and residential aged care
18 April 2020 - The Government will spend almost $300m of its COVID-19 relief fund to buy more PPE, fund medicines ...
Posted by Michael Wonder on 16 Apr 2020
'Pharmacies run off their feet': people waiting days for prescriptions
17 April 2020 - Some patients are waiting days to have their prescriptions filled, with many community pharmacies struggling to ...
Posted by Michael Wonder on 16 Apr 2020
Decision to list terbutaline sulphate powder for inhalation (Bricanyl Turbuhaler) in a new model of the Turbuhaler device
16 April 2020 - PHARMAC is pleased to announce that it has made some changes to the listing of terbutaline ...
Posted by Michael Wonder on 15 Apr 2020
COVID-19: NZ should develop vaccine programme, say scientists
15 April 2020 - New Zealand needs to act now to make sure it's not left behind when a successful ...
Posted by Michael Wonder on 13 Apr 2020
Raising funds for a life-saving drug in the middle of lockdown
14 April 2020 - A Taranaki man who has to raise funds to pay for life-saving drugs is worried the ...
Posted by Michael Wonder on 08 Apr 2020
New treatment "game changer" for cancer patient
8 April 2020 - A South Canterbury cancer patient is anticipating an easier treatment regime with Revlimid, which has now ...
Posted by Michael Wonder on 07 Apr 2020
Fluoxetine: supply issue
7 April 2020 - Supplies of fluoxetine capsules have arrived in New Zealand. It is awaiting release to wholesalers. ...
Posted by Michael Wonder on 06 Apr 2020
COVID-19: suggestions for funding changes
6 April 2020 - PHARMAC is receiving suggestions from many stakeholders about funding changes we could make to support the health ...
Posted by Michael Wonder on 04 Apr 2020
COVID-19: shipment of anti-depressant drug fluoxetine held up by pandemic
4 April 2020 - An ongoing shortage of New Zealand's most common antidepressant during the COVID-19 lockdown has one psychiatrist ...
Posted by Michael Wonder on 02 Apr 2020
Proposal to fund modified release pancreatic enzyme granules (Creon Micro)
2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...
Posted by Michael Wonder on 01 Apr 2020
PHARMAC widens funding for lenalidomide for those with blood cancer
1 April 2020 - Emma Holden was devastated when she learned she had multiple myeloma. ...
Posted by Michael Wonder on 31 Mar 2020
COVID-19: cancer and rare disorder patients 'will die' if PHARMAC doesn't spend money on medicines
31 March 2020 - Those with cancer and rare medical conditions have asked the Prime Minister to relax PHARMAC's rules ...
Posted by Michael Wonder on 31 Mar 2020
New Zealand Pharmaceutical Schedule - 1 April 2020 update
1 April 2020 - The April 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...